Quality Assurance website – Jane Woodland Regional QA Lead Midlands and East

2 Inform and prompt thinking about the implications for NBS laboratories of  New commissioning arrangements  Screening and Quality Assurance in the new NHS/PHE systems

Organisational map National CB and PHE 4 CB and PHE Regions 15 PHE Centres 24 CB Area Teams plus 3 London, 10 specialised commissioning Also Directors of Public Health in Local Authorities Clinical Commissioning Groups/Commissioning Support Units North of England Midlands and East of England South of England London integrated region and centre

4  Public Health England mandates NHS Commissioning Board to commission  Screening  Immunisation  Child health information services  Children’s Public Health (0-5yrs) to 2015  PH for people in prison or other places of detention  Sexual assault referral services

5  Screening and Imms team employed by PHE but work in the AT  Screening and Immunisation Lead  Managerially accountable to NHS CB Head of Public Health Commissioning  Training, development and professional support from PHE Centres

6 Head of Public Health Commissioning Screening/Imms Co-ordinator AfC7 Screening & Immunisation Manager AfC8a/b Screening/Imms Co-ordinator AfC7 Screening/Imms Co-ordinator AfC7 Screening/Imms Co-ordinator AfC7 Procurement Contracting, Finance & Primary Care Contracting CCDC & QA Advice to Imms Admin Support Data/Performance Analyst PHE Specialist staff Seconded to LAT embedded in LAT NHSCB employed staff Screening & Immunisation Lead CPH, 9, 8d PH Role at Public Health centres Screening/Imms Co-ordinator AfC7 Communications Support Screening & Immunisation Manager AfC8a/b

7  Some staff matched to AT posts  Phased recruitment - staff at risk prioritised  Regional Implementation Teams  Principle of managed “hand overs”  Training

8  National service specifications for each programme  13/14 – “steady state”  PHE “owned” but future commissioning implications worked through with NHS CB  Providers to participate in QA and share info re service quality….

9  Ante-natal/new born screening complexity  CCGs commission maternity services  Area Teams “responsible” for screening commissioning  Maternity tariff  Laboratory services largely within tariff NB  Pathology modernisation

10  Part of PHE’s Health & Wellbeing Directorate  Operations Manager – Robert Sheriff  Newborn bloodspot screening, S&T, Infectious diseases – PM tbc  Deputy PMs – Christine Cavanagh, Cathy Coppinger, Sharon Webb  Adult Programmes – PM Anne Stephenson  NIPE, Newborn Hearing & FASP – PM Gwen Carr

11  A systematic programme of activities to monitor performance against pre-set quality standards and support improvement. A Bowling (2002) Research Methods in Health: Investigating Health and Health Services  Screening …….. a programme not a test

8 Quality Assurance Teams…one approach Quality Assurance teams non-cancer screening National QA Director – Sue Cohen Deputy - Val Armstrong Cluster QA Manager – Elizabeth Dormandy Regional QA Leads North – Madeleine Johnson Midlands and East – Jane Woodland South – Morag Amer London – Jan Yates 1 wte – Senior QA manager ANNB 1 wte – QA manager ANNB 1 wte – Senior QA manager – adult programmes 1 wte – QA manager – adult programmes Northern and Yorkshire: 7.9m (15.0%) North West: 7.0m (13.2%) West Midlands: 5.6m (10.6%) East Midlands: 3.6m (6.8%) South West: 4.6m (8.7%) South East: 9.2m (17.4%) London: 8.1m (15.4%) East of England: 6.8m (12.8%) The map shows population sizes in millions and (proportions of the total) as per Census 2011 data, total English population of 52.7m

13 Screening programme objectives (across the pathway) Criteria (measurable) Standard (minimum/achievable)

14 Identify InformOfferTestResultReport ACT

15 QA NSPs providers PHE Centres NHS CB

16

17  Compare and contrast performance between programmes and over time/KPIs  QA visits- ANNB model to be finalised following final pilot ▪ Mix of self assessment & targeted visits ▪ Peer involvement

18  QA visits: focus on interface between laboratories/other providers  Joint approach with CPA/UKAS re lab specific QA  Duty of candour

19  Newborn screening QA project/roll out  Convergence of screening/CPA standards  Costs?  Newborn blood spot failsafe roll out

20